Ohr Pharmaceutical Inc Uncategorized Contracts & Agreements
20 Contracts & Agreements
- Certificate of Dissolution, as filed by NeuBase Therapeutics, Inc. with the Secretary of State of the State of Delaware, effective June 26, 2024 (Filed With SEC on June 27, 2024)
- Plan of Liquidation and Dissolution of NeuBase Therapeutics, Inc (Filed With SEC on March 7, 2024)
- Bill of Sale, dated December 27, 2023, entered into by NeuBase Therapeutics, Inc. for the benefit of University of Pittsburgh of the Commonwealth System of Higher Education (Filed With SEC on December 28, 2023)
- Open Market Sale AgreementSM dated August 27, 2021, by and between NeuBase Therapeutics, Inc. and Jefferies LLC (Filed With SEC on August 27, 2021)
- Description of Securities of NeuBase Therapeutics, Inc (Filed With SEC on January 10, 2020)
- Form of Company and NeuBase Lock-Up Agreements (Filed With SEC on January 3, 2019)
- Form of Support Agreement, by and among NeuBase Therapeutics, Inc., Ohr Pharmaceutical, Inc. and its directors, officers and certain stockholders of NeuBase Therapeutics, Inc (Filed With SEC on January 3, 2019)
- Form of Support Agreement, by and among Ohr Pharmaceutical, Inc., NeuBase Therapeutics, Inc. and the directors and officers of Ohr Pharmaceutical, Inc (Filed With SEC on January 3, 2019)
- Placement Agent Agreement dated as of April 5, 2017, by and among Ohr Pharmaceutical, Inc., Chardan Capital Markets, LLC and H.C. Wainwright & Co., LLC (Filed With SEC on April 6, 2017)
- Letter Agreement, dated December 2, 2016, by and between Ohr Pharmaceutical, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 8, 2016)
- Proprietary Information and Inventions Agreement, dated April 10, 2010, between Ohr Pharmaceutical, Inc. and Sam Backenroth (Filed With SEC on December 14, 2015)
- Proprietary Information and Invention Agreement, dated April 10, 2010, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Lock-up Agreement, dated December 11, 2015, from Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Second Research Agreement, July 31, 2013 (Filed With SEC on August 18, 2014)
- Audit Committee Charter (Filed With SEC on May 24, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 15, 2012)
- OHRPHARMACEUTICAL INC. STOCKOPTION AGREEMENT (Filed With SEC on March 15, 2012)
- OhrPharmaceutical, Inc (Filed With SEC on April 12, 2010)
- OhrPharmaceutical, Inc 1245Brickyard Road, #590 Salt lakeCity, Utah 84106 801-433-2000ph 801-433-2222fx (Filed With SEC on April 12, 2010)
- Material Contract (Filed With SEC on February 16, 2010)
